Inclusion Criteria:  Male or female of non-childbearing potential (NCBP), aged 18-55 years (both inclusive) at the time of signing informed consent. Body mass index (BMI) between 20.0 and 29.9 kg/m^2 (both inclusive).  Exclusion Criteria:  Any disorder which in the investigator's opinion might jeopardise participant's safety or compliance with the protocol. Glycosylated haemoglobin (HbA1c) more than or equal to 6.5 % (48 mmol/mol) at screening. Use of prescription medicinal products or non-prescription drugs, except routine vitamins, occasional use of paracetamol, ibuprofen and acetylsalicylic acid, or topical medication not reaching systemic circulation within 14 days before screening. Presence or history of any clinically relevant respiratory, metabolic, renal, hepatic, cardiovascular, gastrointestinal, or endocrinological conditions.